Cargando…

Ixazomib-Associated Skin Exfoliation

Detalles Bibliográficos
Autores principales:	Zhang, Yali, Zhao, Long, Guo, Yuancheng, Liu, Bei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Università Cattolica del Sacro Cuore 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9083939/ https://www.ncbi.nlm.nih.gov/pubmed/35615328 http://dx.doi.org/10.4084/MJHID.2022.045

Ejemplares similares

Sweet Syndrome Associated with Ixazomib
por: Yavaşoğlu, İrfan, et al.
Publicado: (2021)

A Promising New Therapy of Oral Ixazomib Without Rituximab for Waldenstrom Macroglobulinemia
por: Ma, Wanlu, et al.
Publicado: (2021)

EXFOLIATIVE DERMATITIS DUE TO CARBAMAZEPINE
por: Jayesh, Kanabar
Publicado: (1999)

Ixazomib-thalidomide-low dose dexamethasone induction followed by maintenance therapy with ixazomib or placebo in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplantation; results from the randomized phase II HOVON-126/NMSG 21.13 trial
por: Zweegman, Sonja, et al.
Publicado: (2020)

Nevirapine induced exfoliative dermatitis in an HIV-infected patient
por: Bhandarkar, Anoosha P., et al.
Publicado: (2011)

Scoring criteria for the evaluation of micronuclei in oral exfoliated cells
por: Grover, Sonal, et al.
Publicado: (2017)

Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long-term Results of HOVON-126/NMSG 21.13
por: Groen, Kazimierz, et al.
Publicado: (2023)

Metastatic ampullary adenocarcinoma in exfoliative sputum cytology: A rare presentation
por: Roy, Maitrayee, et al.
Publicado: (2015)

All-oral triplet combination of ixazomib, lenalidomide, and dexamethasone in newly diagnosed transplant-eligible multiple myeloma patients: final results of the phase II IFM 2013-06 study
por: Touzeau, Cyrille, et al.
Publicado: (2022)

Phase 1/2 study of ixazomib with cyclophosphamide and dexamethasone in newly diagnosed AL amyloidosis
por: Rosenbaum, Cara A., et al.
Publicado: (2022)

Comment on Comparison of ocular response analyzer parameters in primary open angle glaucoma and exfoliative glaucoma patients
por: Gundogan, Fatih C, et al.
Publicado: (2015)

Evaluation of cytogenetic damage in exfoliated nasal epithelial cells contributes to a better understanding of the pathogenesis of rhinosinusitis()
por: Souza, Ana Carolina Flygare, et al.
Publicado: (2019)

Re: Evaluation of Micronuclei and Cytomorphometric Changes in Patients with Different Tobacco Related Habits Using Exfoliated Buccal Cells
por: Muradyan, Rafayel E, et al.
Publicado: (2022)

Ixazomib–Thalidomide–Dexamethasone for induction therapy followed by Ixazomib maintenance treatment in patients with relapsed/refractory multiple myeloma
por: Ludwig, Heinz, et al.
Publicado: (2019)

Novel proteasome inhibitor ixazomib sensitizes neuroblastoma cells to doxorubicin treatment
por: Li, Haoyu, et al.
Publicado: (2016)

Ixazomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma: long-term follow-up including ixazomib maintenance
por: Kumar, Shaji K., et al.
Publicado: (2019)

Comparison between ixazomib+cyclophosphamide+dexamethasone regimen and ixazomib+dexamethasone regimen for elderly and frail patients having newly diagnosed multiple myeloma
por: Li, Shutan, et al.
Publicado: (2022)

The anatomy of the skin of the Chinese tree shrew is very similar to that of human skin
por: Zhang, Jing, et al.
Publicado: (2020)

Spotlight on ixazomib: potential in the treatment of multiple myeloma
por: Muz, Barbara, et al.
Publicado: (2016)

T‐cell pseudolymphoma secondary to ixazomib for multiple myeloma
por: Haq, M., et al.
Publicado: (2021)

Combined Therapy with Ixazomib, Lenalidomide, and Dexamethasone for Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome
por: Suichi, Tomoki, et al.
Publicado: (2022)

Ixazomib-associated tumor lysis syndrome in multiple myeloma: A case report
por: Jin, Fengbo, et al.
Publicado: (2020)

Ixazomib: An Oral Proteasome Inhibitor for the Treatment of Multiple Myeloma
por: Ramirez, Krista G.
Publicado: (2017)

Clinical Pharmacology of Ixazomib: The First Oral Proteasome Inhibitor
por: Gupta, Neeraj, et al.
Publicado: (2018)

Accidental Ixazomib Overdose in a Patient With Multiple Myeloma
por: Sampat, Parth J., et al.
Publicado: (2021)

Ixazomib-induced Sweet’s syndrome: A case report
por: Bellemare, Jeanne, et al.
Publicado: (2023)

Model‐Informed Drug Development for Ixazomib, an Oral Proteasome Inhibitor
por: Gupta, Neeraj, et al.
Publicado: (2018)

Irritated Skin Is Not Sensitive Skin
por: Misery, Laurent
Publicado: (2021)

P978: IXAZOMIB VERSUS LENALIDOMIDE OR IXAZOMIB AND LENALIDOMIDE COMBINATION AS MAINTENANCE REGIMEN FOR PATIENTS WITH MULTIPLE MYELOMA: INTERIM ANALYSIS OF A MULTI-CENTER PROSPECTIVE STUDY IN CHINA
por: Zhuang, Z., et al.
Publicado: (2022)

P873: IXAZOMIB VERSUS LENALIDOMIDE OR IXAZOMIB AND LENALIDOMIDE COMBINATION AS MAINTENANCE REGIMEN FOR TRANSPLANT-INELIGIBLE MULTIPLE MYELOMA: UPDATE OF A MULTI-CENTER PROSPECTIVE STUDY IN CHINA
por: Zhuang, Zhe, et al.
Publicado: (2023)

A case of skin lesions of basal cell nevus syndrome
por: Chen, Long, et al.
Publicado: (2021)

Drug-Induced Thrombotic Microangiopathy due to Cumulative Toxicity of Ixazomib
por: Atallah-Yunes, Suheil Albert, et al.
Publicado: (2018)

Exfoliative Skin-peeling, Benefits from This Procedure and Our Experience
por: Grajqevci-Kotori, Merita, et al.
Publicado: (2015)

Myeloid dendritic cells are increased in the lesional skin and associated with pruritus in patients with prurigo nodularis
por: Liu, Taoming, et al.
Publicado: (2023)

Real World Efficacy and Safety Results of Ixazomib Lenalidomide and Dexamethasone Combination in Relapsed/Refractory Multiple Myeloma: Data Collected from the Hungarian Ixazomib Named Patient Program
por: Varga, Gergely, et al.
Publicado: (2019)

CT imaging of coronavirus disease 2019 (COVID-19): from the qualitative to quantitative
por: Qi, Xiaolong, et al.
Publicado: (2020)

A case of foreign body in the skin
por: Zhang, Bin, et al.
Publicado: (2019)

Exfoliation in a low boiling point solvent and electrochemical applications of MoO(3)
por: Sricharan, Matangi, et al.
Publicado: (2020)

Exfoliation Syndrome and Exfoliation Glaucoma in the Navajo Nation
por: Patil, Ayesha, et al.
Publicado: (2022)

New developments in the management of relapsed/refractory multiple myeloma – the role of ixazomib
por: Richardson, Paul G, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lsvv86i9hpr1s5n07nfl3v0sh0